Nikhil Panicker, PhD

2009-2016 Biomedical science Iowa State University, Ames, IA, United States 
 2016- Johns Hopkins University School of Medicine, Baltimore, MD, United States 
"Nikhil S Panicker"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Panicker N, Ge P, Dawson VL, et al. (2021) The cell biology of Parkinson's disease. The Journal of Cell Biology. 220
Sarkar S, Nguyen HM, Malovic E, et al. (2020) Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease. The Journal of Clinical Investigation
Saminathan H, Charli A, Luo J, et al. (2020) Fyn kinase mediates pro-inflammatory response in a mouse model of endotoxemia: Relevance to translational research. European Journal of Pharmacology. 173259
Panicker N, Kanthasamy A, Kanthasamy AG. (2019) Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease. Aging
Kim S, Kwon SH, Kam TI, et al. (2019) Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron
Panicker N, Sarkar S, Harischandra DS, et al. (2019) Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia. The Journal of Experimental Medicine
Harischandra DS, Rokad D, Neal ML, et al. (2019) Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein. Science Signaling. 12
Kam TI, Mao X, Park H, et al. (2018) Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease. Science (New York, N.Y.). 362
Yun SP, Kam TI, Panicker N, et al. (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nature Medicine
Sarkar S, Malovic E, Harishchandra DS, et al. (2017) Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease. Npj Parkinson's Disease. 3: 30
See more...